-       Report 
- March 2025
-  137 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
            -       Report 
- September 2025
-  150 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- January 2025
-  150 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- January 2025
-  181 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
            -       Report 
- August 2025
-  194 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
             -       Report 
- August 2025
-  185 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  388 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  501 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  268 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  384 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  465 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  354 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  372 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- August 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- July 2025
-  179 Pages 
- Global 
   From       €3219EUR$3,599USD£2,832GBP 
            -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €2927EUR$3,273USD£2,575GBP 
      €3444EUR$3,850USD£3,029GBP 
          -       Report 
- September 2025
-  83 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
            -       Report 
- October 2025
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
          -       Report 
- May 2025
-  100 Pages 
- United States 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- July 2024
-  200 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
       
      Lameness is a condition in animals that affects their ability to walk or move normally. It is a common problem in veterinary medicine, and can be caused by a variety of factors, including injury, infection, arthritis, and other diseases. Treatment of lameness in animals typically involves a combination of rest, physical therapy, and medications. In some cases, surgery may be necessary to correct the underlying cause of the lameness.
The animal healthcare/veterinary market for lameness is highly    competitive, with a variety of companies offering products and services to diagnose and treat the condition. These include pharmaceutical companies that produce medications to treat lameness, as well as companies that specialize in physical therapy and rehabilitation. Additionally, there are companies that provide diagnostic imaging and other services to help veterinarians diagnose and treat lameness.
Some companies in the lameness market include Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Zoetis, and Ceva Animal Health. Show Less   Read more